WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5901 Infant (under 12 months) mortality rate: 632
GDP / capita (US$): 1'0451 Child (under 5 years) mortality rate: 902

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 25'834  25'203  24'581  23'967  23'361  18'276  13'568  12'142 
Births 1'005  995  985  975  966  814  607  563 
Surviving infants 932  920  908  897  886  727  522  482 
Pop. less than 5 years 4'399  4'332  4'280  4'243  4'194  3'177  2'366  2'172 
Pop. less than 15 years 11'723  11'439  11'150  10'868  10'587  8'005  6'316  5'321 
Female 15-49 years 5'937  5'807  5'683  5'559  5'436  4'479  3'109  2'847 

Number of reported case

(Click for retrospective incidence data for Mozambique)
Diphtheria 11 
Japanese encephalitis
Measles 145  177  2'321  60  7'375  18'082  30'070 
Mumps
Pertussis 94  451 
Polio* 65 
Rubella 127  428  143  70  69 
Rubella (CRS)
Tetanus (neonatal) 59  47  72  41  42  34  101 
Tetanus (total) 59  110  60  41  65  102  573 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mozambique)
Vaccine year result method % card seen                                                
BCG 2010  91  DHS   83  93  91  91  90  90  99*  59 
DTP1 2010  91  DHS   83  93  91  91  77  90  99* 
DTP3 2010  76  DHS   83  78  76  76  74  76  88  46 
HepB_BD         
HepB3          78  76  76  74  76 
Hib3          78  76  76  74  74 
JapEnc         
MCV 2010  82  DHS   83  85  82  82  70  67  97  59 
MCV2         
PCV1          80 
PCV3          60 
Pol3 2010  73  DHS   83  78  73  73  73  76  87  46 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  56  DHS   83  64  70  70  69  60  61  21 
PAB         
VAD1          59  60  31  51 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mozambique)
BCG 93  91  91  90  90  84  59 
DTP1 93  91  91  91  89  84  71 
DTP3 78  76  76  74  74  70  46 
HepB3 78  76  76  74  74 
HepB_BD
Hib3 78  76  76  74  74 
MCV 85  82  82  82  80  71  59 
MCV2
PAB 83  83  83  83  83  75  37 
PCV3 45 
Pol3 78  73  73  73  74  69  46 
Rota_last

Number of districts in the country 148  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 66
From 80 to 89% 20
From 50 to 79% 11
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years;
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2012-2016  2012-2016  2009-2013  2009 - 2013  2007 - 2009  2007 - 2009 
Nº of districts with microplans that include activities to raise immunization coverage number 148  148  144  66  66  33  33 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No       

System performance

Total Nº districts in country number 148  148  144  144  144  144  144 
Nº districts with DTP3 coverage >=80% number 128  136  98  43  118  105  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 86  92  68  30  82  73 
Nº districts with measles (MCV1) coverage >=95% number 44  63  42  70  76  56   
% of districts with MCV1 coverage >=95% From 0 to 100% 30  43  29  49  53  39   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 20  30  20  27  100  100   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.